X
CL icon

Xponance’s Colgate-Palmolive CL Stock Holding History

Xponance’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Sell
195,036
-31,479
-14% -$2.75M 0.11% 142
2026
Q1 		$19.3M Buy
226,515
+66,247
+41% +$5.9M 0.14% 121
2025
Q4 		$12.7M Sell
160,268
-23,331
-13% -$1.83M 0.1% 167
2025
Q3 		$14.7M Buy
183,599
+23,807
+15% +$2.03M 0.12% 137
2025
Q2 		$14.5M Buy
159,792
+7,534
+5% +$688K 0.12% 142
2025
Q1 		$14.3M Sell
152,258
-689
-0.5% -$61.7K 0.14% 122
2024
Q4 		$13.9M Sell
152,947
-10,212
-6% -$974K 0.13% 121
2024
Q3 		$16.9M Sell
163,159
-28,960
-15% -$2.95M 0.16% 96
2024
Q2 		$18.6M Buy
192,119
+1,795
+0.9% +$166K 0.19% 86
2024
Q1 		$17.1M Buy
190,324
+7,549
+4% +$640K 0.18% 97
2023
Q4 		$14.6M Buy
182,775
+13,342
+8% +$1M 0.17% 101
2023
Q3 		$12M Buy
169,433
+34,154
+25% +$2.55M 0.16% 106
2023
Q2 		$10.4M Sell
135,279
-15,948
-11% -$1.23M 0.14% 122
2023
Q1 		$11.4M Buy
151,227
+649
+0.4% +$48.3K 0.17% 116
2022
Q4 		$11.9M Buy
150,578
+15,816
+12% +$1.19M 0.19% 106
2022
Q3 		$9.47M Buy
134,762
+13,783
+11% +$1.08M 0.18% 106
2022
Q2 		$9.7M Buy
120,979
+17,000
+16% +$1.33M 0.19% 96
2022
Q1 		$7.88M Buy
103,979
+1,976
+2% +$157K 0.13% 132
2021
Q4 		$8.71M Buy
102,003
+11,462
+13% +$895K 0.14% 132
2021
Q3 		$6.84M Sell
90,541
-4,041
-4% -$321K 0.13% 140
2021
Q2 		$7.69M Buy
94,582
+55,409
+141% +$4.53M 0.14% 125
2021
Q1 		$3.09M Sell
39,173
-33,472
-46% -$2.62M 0.07% 238
2020
Q4 		$6.21M Buy
72,645
+945
+1% +$78.1K 0.14% 133
2020
Q3 		$5.53M Buy
71,700
+33,823
+89% +$2.58M 0.14% 136
2020
Q2 		$2.77M Buy
+37,877
New +$2.69M 0.07% 220

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Xponance's CL Position: Q2 2026 in Review

Xponance reduced its Colgate-Palmolive (CL) stake by 14% in Q2 2026, selling an estimated $2.75M and leaving 195,036 shares worth $17.9M. The position accounts for 0.11% of the portfolio, ranked #142.

Xponance first reported a position in CL in Q2 2020 and has held it in 25 quarters since. The position peaked at $19.3M in Q1 2026. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Xponance held 195,036 shares of Colgate-Palmolive worth $17.9M as of Q2 2026.
  • Xponance sold 31,479 Colgate-Palmolive shares in Q2 2026, an estimated $2.75M.
  • Colgate-Palmolive made up 0.11% of Xponance's portfolio in Q2 2026, its #142 holding.
  • Xponance first reported a position in Colgate-Palmolive in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Colgate-Palmolive position peaked at $19.3M in Q1 2026.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.